PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
12-Jan-2022 TÜV SÜD Announces Medical Device Testing Laboratory Expansion, Adding 26 High-Skilled Job Opportunities in New Brighton, MN Businesswire
12-Jan-2022 ICON Issues Financial Guidance for Full Year 2022 Businesswire
12-Jan-2022 Aro Biotherapeutics Expands Leadership Team with Appointment of Sukumar Sakamuri, Ph.D. as Chief Technology Officer Businesswire
12-Jan-2022 Glytec and Roche Announce Strategic Partnership to Bring Digital Health Innovation in Glycemic Decision Support to the Hospital Bedside Businesswire
12-Jan-2022 Global Pharma and Biotech Discovery Stage Partnering Terms and Agreements Report 2021 with Case Studies of Real-life Discovery Stage Deals - ResearchAndMarkets.com Businesswire
12-Jan-2022 Global Pharma and Biotech Preclinical Stage Partnering Deal Terms and Agreements Analysis Report 2021 - ResearchAndMarkets.com Businesswire
12-Jan-2022 Global Pharma and Biotech Clinical Stage Partnering Deals Analysis Report 2021 - ResearchAndMarkets.com Businesswire
12-Jan-2022 Global Healthcare Regulatory Affairs Outsourcing Market Outlook, 2028 - Advancements in Specialty Therapies, Orphan Drugs, and Personalized Medicines Presents Lucrative Opportunities - ResearchAndMarkets.com Businesswire
12-Jan-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
12-Jan-2022 Liverpool CCG and Community Pharmacy Liverpool Launch FebriDx® Service at More Than 100 Community Pharmacies Businesswire
12-Jan-2022 Medisca Signs Deal as Exclusive Global Distributor outside the USA & Israel for the Padagis Line of ORA Products Businesswire
12-Jan-2022 Lost Money in Revance Therapeutics, Inc.? Businesswire
11-Jan-2022 Nanobiotix: Statement of Total Voting Rights and Shares Forming the Company’s Share Capital Businesswire
11-Jan-2022 Glaukos’ iDose® TR Demonstrates Sustained IOP Reduction and Favorable Safety Profile Over 36 Months in Phase 2b Study Businesswire
11-Jan-2022 Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Presbyopia Businesswire
11-Jan-2022 Glaukos Announces First Patient Enrolled in Phase 2 Clinical Trial for Dry Eye Disease Businesswire
11-Jan-2022 Samenvatting: Takeda benadrukt strategie voor het realiseren van duurzame groei in het komende decennium op de 40e jaarlijkse J.P. Morgan Healthcare Conference Businesswire
11-Jan-2022 La 40e conférence annuelle J.P. Morgan sur les soins de santé voit Takeda détailler sa stratégie pour générer une croissance durable ces dix prochaines années Businesswire
11-Jan-2022 Global Small-Molecule Injectable Market (2021 to 2031) - Analysis, Outlook, Growth, Trends and Forecasts - ResearchAndMarkets.com Businesswire
11-Jan-2022 2021 Insights on the Global Aesthetic Devices Industry - Featuring Aesthetic Medical Device, Aesthetics Point and Allergan Aesthetics Among Others - ResearchAndMarkets.com Businesswire